14 December 2020 - Late treatment study
A retrospective comparison of drugs against COVID-19
et al., Virus Research, doi:10.1016/j.virusres.2020.198262 (Peer Reviewed)
Retrospective 333 patients in China, with only 8 HCQ patients, showing shorter duration of hospitalization with HCQ.
|
hospitalization time, 35.2% lower, relative time 0.65, p = 0.04, treatment 8, control 277.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Tan et al., 12/14/2020, retrospective, China, Asia, peer-reviewed, 7 authors.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.